Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

ATP7B Knockout K562 Polyclonal Cells

ATP7B Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP7B was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20266

ATP6V1C2 Knockout K562 Polyclonal Cells

ATP6V1C2 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP6V1C2 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20265

ABHD17C Knockout Hela Polyclonal Cells

ABHD17C Knockout Hela Polyclonal Cells is a knockout polyclonal cell population. The ABHD17C was knocked out in the Hela cells using the CRISPR RNP technique.
Cat. No. ARG20264

ATP6V0A2 Knockout K562 Polyclonal Cells

ATP6V0A2 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP6V0A2 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20263

ATP1B1 Knockout K562 Polyclonal Cells

ATP1B1 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP1B1 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20262

ATP13A2 Knockout K562 Polyclonal Cells

ATP13A2 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP13A2 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20261

ATP13A1 Knockout K562 Polyclonal Cells

ATP13A1 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP13A1 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20260

ATP11C Knockout K562 Polyclonal Cells

ATP11C Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP11C was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20259

ATP11A Knockout K562 Polyclonal Cells

ATP11A Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATP11A was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20258

ATOX1 Knockout K562 Polyclonal Cells

ATOX1 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATOX1 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20257

ATM Knockout K562 Polyclonal Cells

ATM Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATM was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20256

ATG9A Knockout K562 Polyclonal Cells

ATG9A Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG9A was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20254

Loading products...